EBSCX | JDJAX | EBSCX / JDJAX | |
Total Expense Ratio | 2.75 | 1.61 | 171% |
Annual Report Gross Expense Ratio | 2.84 | 1.62 | 175% |
Fund Existence | 11 years | 6 years | - |
Gain YTD | 1.330 | -5.876 | -23% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.94B | 1.36B | 142% |
Annual Yield % from dividends | 0.42 | 0.18 | 234% |
Returns for 1 year | 6.01 | -14.27 | -42% |
Returns for 3 years | -1.77 | -7.26 | 24% |
Returns for 5 years | 26.91 | 11.54 | 233% |
Returns for 10 years | 8.50 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SASVX | 5.99 | N/A | N/A |
Virtus Ceredex Small-Cap Value Eq A | |||
CNRVX | 23.41 | -0.01 | -0.04% |
City National Rochdale US Cor Eq Svc | |||
FGSIX | 62.30 | -0.09 | -0.14% |
Federated Hermes MDT Mid Cap Growth IS | |||
FGCKX | 36.63 | -0.10 | -0.27% |
Fidelity Growth Company K | |||
DBMCX | 20.87 | -0.22 | -1.04% |
BNY Mellon Sm/Md Cp Gr C |